Raymond James reduced their FY2024 earnings estimates for goeasy in a research report issued to clients and investors on ...

Investment analysts at Desjardins lowered their FY2024 earnings per share estimates for goeasy in a research report issued to clients and investors on Monday, January 27th. Desjardins analyst G. Ho ...

We recently published a list of 12 Best Chemical Stocks to Buy According to Analysts. In this article, we are going to take a ...

BMO Capital Markets adjusted its outlook on Selective Insurance Group (NASDAQ:SIGI) shares, reducing the price target from ...

BMO Capital Markets has promoted Vivek Baliga from head of non-agency RMBS trading in New York to head of non-agency, ABS and ...

BMO Capital Markets increased its price target on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares, moving the ...

In this article, we will discuss the 12 Best Chemical Stocks to Buy According to Analysts.

Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth.

Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.

Discover top quality stocks for long-term investment to guard against volatility and benefit during market strength.

The U.S. economy grew 2.3% in the fourth quarter as consumers again powered gains. Here's what the showing could mean for Fed ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 56.32% ...